Please login to the form below
Questions surrounding remdesivir treatment for COVID-19 are ‘complicated’, says NEJM
Editorial highlights issues with WHO’s Solidarity trial
WHO set to review Pfizer/BioNTech COVID-19 vaccine for emergency use listing
Follows approval for emergency use in the UK yesterday
US secures 650,000 additional doses of Lilly’s COVID-19 antibody
This takes the total purchased amount to 950,000 doses
Novavax moves closer toward launch of US phase 3 COVID-19 vaccine trial
Company also completes enrolment in UK-based phase 3 trial
Sanofi Genzyme takes home New Product Introductions Award at PMEA 2020
Winning entry stood out in a strong category
EMA launches rolling review of J&J’s COVID-19 vaccine
Vaccine entered phase 3 testing in September
Pfizer/BioNTech’s COVID-19 vaccine gets first approval from UK
The UK has already signed a supply deal for 40 million doses
NHS set to pilot GRAIL’s wide-ranging cancer blood test
Previous study indicates test can detect over 50 cancer types
AZ divests European rights for cholesterol med Crestor to Grünenthal
Grünenthal will pay up to $350m for the rights
Q&A: Caroline Gosling
PME interviews Rubica's Director of Culture & Engagement
-
Q&A: Isabel GibsonPME interviews W2O ISO's Managing Director
-
Q&A: Kate Callan
-
Joint COVID-19 trial begins testing drugs from Amgen, UCB and TakedaTrial will test therapeutic candidates in hospitalised COVID-19 patients
-
Moderna eyes COVID-19 vaccine approval in the US and the EUUpdated analysis demonstrates efficacy of 94.1%
-
AZ, Oxford University face more scrutiny over COVID-19 vaccine dataWHO’s immunisations director says ‘more than a press release’ is needed
-
COVID-19 infections in England drop by 30% amid national lockdownObservations come from REACT study led by Imperial College London and Ipsos MORI
-
Moderna and UK sign agreement for additional doses of COVID-19 vaccine
The UK has secured another two million doses on top of previously agreed five million doses
-
Biogen signs $3.1bn deal with Sage for potential depression therapies Zuranolone already has a breakthrough therapy designation from the US FDA
-
PMEA 2020: continuing to recognise excellence in improving patient outcomesThe 20th annual PMEAs took place virtually this year due to COVID-19
Latest appointments
-
OPEN Health names Rob Barker chief executive officerBarker succeeds outgoing OPEN Health CEO and co-founder David Rowley
-
Merck’s R&D chief Roger Perlmutter heads for the exit as Dean Li takes the helm Perlmutter is set to join the board of AI drug discovery biotech Insitro
-
90TEN bolsters senior management team Agency establishes new role of head of behavioural science
-
Evoke KYNE promotes Dante DelVecchio to senior VP DelVecchio takes on the role after ten years at Evoke KYNE
-
McCann Health North America appoints Jim Joseph as president Joseph will oversee all North American advertising and promotion agencies in the US and Canada
COVID-19 Updates and Daily News
Featured jobs
-
Senior Leader
-
Exceptionally competitive salary
-
Healthcare Account Director
-
Competitive
-
Healthcare Senior Account Manager
-
Competitive
-
Healthcare Lead Copywriter
-
Competitive
-
Medical Editor
-
Competitive
- AZ, Oxford University face more scrutiny over COVID-19 vaccine data
- GSK, Medicago launch phase 2/3 clinical trials of plant-derived COVID-19 vaccine
- Roche’s Xofluza pill wins FDA approval for post-exposure flu prevention
- Synairgen’s SNG001 advances into phase 3 COVID-19 trial
- UK could approve Pfizer’s COVID-19 vaccine this week
- New study identifies drugs that are safe to use in COVID-19 treatment
- Live Webinar: Artificial Intelligence for Identifying and Monitoring Cognitive Decline
- The Future of Wearable and Implantable Devices
- Designing Ethical AI and Healthcare Technologies
- Attacking COVID-19 from All Angles
- Questions surrounding remdesivir treatment for COVID-19 are ‘complicated’, says NEJM
- Not waving but drowning. Reflections on data curation in the age of information overload
PMHub
Merrill Brink International
Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....
Latest intelligence
- Not waving but drowning. Reflections on data curation in the age of information overload
- ...
- Digital healthcare may revolutionise management of chronic diseases, but who is going to pay for it?
- Providers are looking at digital solutions to transform this area of healthcare...
- Live webinar:
- The power of a good story: Turn your insights into effective storytelling with data visualisation...
Quick links
Infographics
